This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Vital Signs Solutions Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kiran Roest - Innovator in Liquid Analysis Technology
Introduction
Kiran Roest is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of liquid analysis, particularly in the detection of biomarkers. His innovative approach combines microfluidic technology with user-friendly design, making it accessible for various applications.
Latest Patents
Kiran Roest holds a patent for a device and method for liquid analysis to detect biomarkers. This device enables users to detect biomarkers through a system of microfluidic channels that connect an inlet duct to an outlet duct. The design allows for the introduction of a drop of body fluid, with a resilient bladder providing suction at the outlet. Each microfluidic channel contains a reaction chamber with biomarker-sensitive reagents that change color in the presence of specific biomarkers. The transparency of the device allows users to observe these color changes, and it includes magnifying lenses for enhanced visibility. Additionally, the device can be used in conjunction with a smartphone, further increasing its practicality.
Career Highlights
Kiran Roest is currently associated with Vital Signs Solutions Limited, where he continues to develop innovative solutions in the field of health technology. His work focuses on enhancing the accuracy and efficiency of biomarker detection, which is crucial for medical diagnostics.
Collaborations
Kiran collaborates with Vladimir Gubala, contributing to the advancement of their projects and sharing expertise in their respective fields.
Conclusion
Kiran Roest's contributions to liquid analysis technology exemplify the impact of innovation in healthcare. His patented device represents a significant step forward in the detection of biomarkers, showcasing the potential for improved medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile